aureus, Decolonization of Carriers, and Perioperative Antimicrobial Prophylaxis Patchen Dellinger, MD - Professor of Surgery

187 WEDNESDAY SCIENTIFIC SESSIONS Final Program ------------------------------------------------------------------------ 231 K Symposium A Multifaceted Approach to Preventing Surgical Site Infections Wednesday, 9:15 a.m.–11:15 a.m. . . . . . . . . . . . . . . . . Room 121 UAN: 0391-9999-12-170-L04-P Developed in Cooperation with the Surgical Infection Society SIS Conveners: Jan Kluytmans, MD, PhD - Professor Amphia Hosp., Breda, Netherlands. E. Patchen Dellinger, MD - Professor Univ. of Washington, Seattle, WA. Speakers: 9:15 a.m. 1876 Implementing a Bundle Strategy to Prevent Surgical Site Infections Jan Kluytmans, MD, PhD - Professor Amphia Hosp., Breda, Netherlands. 9:45 a.m. 1877 Meta-Analysis of Studies Evaluating Preoperative Screening for

S. aureus, Decolonization of Carriers, and Perioperative Antimicrobial Prophylaxis

Marin Schweizer, PhD - Assistant Professor Carver Coll. of Med., Iowa City, IA. 10:15 a.m. 1878 Should Perioperative Prophylaxis for Non-Abdominal Procedures Include Coverage for Gram-Negative Organisms and Data from the Swiss National Surveillance System? Andreas Widmer, MD, MS - Deputy Head of Div. Infectious Diseases Hospital Epidemiology Univ. Hosp., Basel, Switzerland. 10:45 a.m. 1879 The New ASHPSHEAIDSASIS Guidelines for Surgical Prophylaxis

E. Patchen Dellinger, MD - Professor of Surgery

Univ. of Washington, Seattle, WA. Objectives: Upon completion of this Symposium Session, the participant should be able to: Discuss pros and cons of including specific interventions in a bundle to prevent SSIs; Discuss the evidence supporting screening patients undergoing cardiac or orthopedic procedures for Staphylococcus aureus; Discuss the evidence addressing whether perioperative prophylaxis for non-abdominal procedures should include coverage for gram-negative organisms; and Discuss important changes in the ASHPSHEAIDSASIS guidelines for perioperative antimicrobial prophylaxis. Intended Audience: Clinical microbiologists, especially those whose labo- ratories may be asked to process preoperative screening tests for S. aureus; infectious disease physicians; physicians and microbiologists involved in infection prevention. Level: All Levels ------------------------------------------------------------------------ 232L1, G Symposium What’s New with Pneumococcus? Wednesday, 9:15 a.m.–11:15 a.m. . . Esplanade Ballroom 308 UAN: 0391-9999-12-171-L04-P Conveners: Keith P. Klugman, MD, PhD - William F. Foege Professor of Global Health Rollins Sch. of Publ. Hlth., Emory Univ., Atlanta, GA. Patrick G. P. Charles, MBBS, PhD - Infectious Diseases Physician Austin Hlth., Heidelberg VIC, Australia. Speakers: 9:15 a.m. 1880 What is the Clinical Impact of Penicillin Non-Susceptibility on Treatment Outcomes for Meningitis and Invasive Pneumococcal Disease? Keith P. Klugman, MD, PhD - William H. Foege Professor of Global Health Rollins Sch. of Publ. Health, Emory Univ., Atlanta, GA. 9:35 a.m. 1881 Extensive Genomic Diversity and Plasticity among Streptococcus pneumonia Strains

N. Luisa Hiller, PhD; Ctr. for Genomic Sciences, Allegheny Gen. Hosp., Pittsburgh, PA.